Dr. Michael Fisher is Professor of Pediatrics (Perelman School of Medicine at the University of Pennsylvania), Chief of the Neuro-Oncology Section (Division of Oncology), Director of the Neurofibromatosis (NF) Program, and the Hubert J.P. and Anne Faulkner Schoemaker Endowed Chair in Pediatric Neuro-Oncology at The Children's Hospital of Philadelphia.  His research focuses on identifying new treatments and novel biomarkers and exploring functional outcomes for children with brain tumors and tumors associated with NF1.  Dr. Fisher is Group Chair of the Department of Defense NF Clinical Trials Consortium and a member of the Steering Committee for REiNS (Response Evaluation in Neurofibromatosis and Schwannomatosis), an international effort to develop standardized outcome measures for clinical trials.  He is Co-Chair of the Quality of Life/Late Effects Committee of the Pediatric Low Grade Astrocytoma Coalition, a member of the Executive Committee for the Collaborative Network for NeuroOncology Clinical Trials (CONNECT), and a member of the CNS Committee of the Children’s Oncology Group.  In addition, he serves as co-leader of an international, multi-institutional, prospective longitudinal natural history study of children with newly diagnosed NF1-associated optic pathway glioma.